Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_assertion type Assertion NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_head.
- NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_assertion description "[In breast cancers expressing estrogen receptors (ERs), level of CYP1B1 is increased by E2 and reversed by an estrogen receptor antagonist, ICI 182,780 or 4-hydrotamoxifen, which indicates that the expression of CYP1 family in downstream region of AhR is regulated by an activation of ER?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_provenance.
- NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_assertion evidence source_evidence_literature NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_provenance.
- NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_assertion SIO_000772 25448748 NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_provenance.
- NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_assertion wasDerivedFrom befree-2016 NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_provenance.
- NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_assertion wasGeneratedBy ECO_0000203 NP1242365.RAKrtl-k-Blki4uXFurCYFp--Cg-QPIxSZMfvNaxvN_ek130_provenance.